Osakidetza Awards €49 Million contract for Knee Prostheses & Implant

Standfirst

Osakidetza, the Basque Health Service, has awarded a major framework agreement valued at approximately 22.2 million euros for the supply of knee prostheses and necessary implantation components. The procurement covers 13 distinct lots addressing various orthopedic needs, ranging from primary replacements to complex tumor prostheses and antiallergic implants.

This tender result highlights the strategic approach of the regional health authority to maintain clinical excellence through a framework that allows for the reopening of competition. Multiple specialized suppliers secured positions, ensuring a diverse and resilient supply chain for regional hospitals while prioritizing advanced surgical outcomes.

Introduction

The continuous modernization of orthopedic care requires a reliable and highly specialized supply of medical devices to support complex surgical interventions. In the Basque Country, the regional health authority has initiated a targeted procurement strategy to equip its hospitals with advanced knee prostheses and associated surgical components. This recent contract award ensures that medical professionals have uninterrupted access to the specific implants required for diverse patient anatomies and clinical conditions.

By executing this procurement through an open procedure, the contracting authority ensured rigorous evaluation of both technical quality and financial efficiency. The selection criteria heavily weighted clinical outcomes and international registry data alongside cost considerations. This holistic approach guarantees that public funds are deployed efficiently while prioritizing patient safety and operational excellence in specialized surgical environments.

Why This Contract Matters

This procurement is vital for ensuring that regional healthcare facilities can perform life saving orthopedic surgeries without interruption due to equipment shortages. The inclusion of specialized lots for antiallergic implants and robotic surgery compatibility demonstrates a forward looking approach to patient care. For the medical device industry, securing a position in this public procurement validates the technical superiority of the awarded products.

It also demonstrates how regional authorities can leverage framework agreements with reopening of competition to drive continuous improvement in healthcare delivery. This structure allows the health service to adapt to evolving clinical guidelines and technological advancements over the contract duration. Suppliers must continuously innovate to meet the stringent quality metrics outlined in the bidding documents.

Contract Timeline

The procurement process concluded with the formal selection of the winning bidders on August 17, 2026. Following standard administrative procedures and mandatory standstill periods, the formal framework agreements were concluded on the same date.

The official contract awards notice was published in the Official Journal of the European Union on September 24, 2026. This timeline reflects a standard and transparent execution of public procurement regulations in the Spanish healthcare sector.

Contract Overview

The procurement is structured as a framework agreement with reopening of competition, divided into 13 distinct lots covering a wide array of orthopedic devices. The maximum awarded value of the framework agreements is 22,272,265.00 euros, reflecting a substantial investment in specialized medical supplies.

The suppliers are responsible for delivering these devices in accordance with strict clinical specifications and maintaining consistent supply levels throughout the agreement duration. The reopening mechanism ensures that pricing and technical offerings remain competitive for future call offs.

Key Contract Details

Project Scope

The core scope involves the supply of highly specialized medical devices for orthopedic surgery units. This includes primary and revision total knee prostheses, medial pivot designs, unicondylar implants, and patellofemoral replacements. The framework also encompasses specialized needs such as antiallergic components for sensitive patients, navigation system compatibility, arthrodesis nails, and complex tumor prostheses.

The contracting authority evaluated bids based on implant design quality, instrument versatility, and survival rates recorded in international registries. Additional criteria included the provision of complementary services, such as surgical training and hospital support, ensuring that the supplied devices integrate smoothly into existing clinical workflows and robotic surgery platforms.

About the Contracting Authority

Osakidetza, Servicio Vasco de Salud is the primary buyer for this procurement. It is a regional public authority responsible for managing and delivering healthcare services across the Basque Country, ensuring high standards of medical care for the local population.

About the Organisations Involved

Osakidetza, Servicio Vasco de Salud is the contracting authority and buyer. It manages regional public health services and drives the procurement of essential medical supplies for public hospitals.

Zimmer Biomet Spain, S.L.U. is a successful bidder and a micro, small, or medium enterprise. It secured positions across seven lots, including primary and revision total knee prostheses, unicondylar implants, and patellofemoral replacements, demonstrating strong market presence.

Establecimientos Sumisan, S.A. is a successful bidder and a micro, small, or medium enterprise. It secured positions in Lot 1 and Lot 13, covering primary knee prostheses and complex tumor prostheses.

Johnson and Johnson, S.A. is a successful bidder and a micro, small, or medium enterprise. It secured a position in Lot 1 for primary and revision total knee prostheses.

Medacta España, S.L. is a successful bidder and a micro, small, or medium enterprise. It secured a position in Lot 2 for medial pivot knee prostheses.

Palex Medical, S.A. is a successful bidder and a micro, small, or medium enterprise. It secured positions in Lot 2 and Lot 10, covering medial pivot and antiallergic medial pivot prostheses.

Traumédica, S.L. is a successful bidder and a micro, small, or medium enterprise. It secured a position in Lot 9 for antiallergic patellofemoral prostheses.

Medicina Analítica Consumibles MAC, S.A. is a successful bidder and a micro, small, or medium enterprise. It secured a position in Lot 11 for navigation system compatible prostheses.

Waldemar Link España, S.A. is a successful bidder and a micro, small, or medium enterprise. It secured a position in Lot 12 for arthrodesis nails.

Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi is the review organisation. This administrative body handles any legal appeals or disputes related to public procurement procedures in the Basque Country.

Procurement Analysis

The open procedure attracted varying levels of competition across the 13 lots, with bid counts generally ranging from one to seven submissions per lot. The award criteria utilized a balanced approach, assigning significant weight to technical quality and clinical evidence alongside a 50 percent weight to price.

This evaluation method indicates that the clinical baselines were strict, ensuring that only highly capable firms with proven track records could advance to the final selection. Notably, all received bids originated from micro, small or medium enterprises, highlighting the strong presence of specialized agile firms in the regional medical device market.

Additional Procurement Facts

The procurement project is not financed with European Union funds, relying entirely on the regional healthcare budget of the Basque Country. The procedure is covered by the Government Procurement Agreement, allowing international suppliers to participate in the bidding process.

Market & Industry Perspective

The Spanish medical device market for orthopedics is characterized by a strong presence of established multinational manufacturers alongside specialized domestic distributors. The success of multiple winners across different lots highlights the importance of clinical efficacy and regulatory compliance in winning major public contracts.

Suppliers must continuously update their product lines to align with evolving medical standards and the specific requirements detailed in GPNs and BOQs. The dominance of small and medium enterprises in this tender result suggests that specialized niche expertise is highly valued alongside the broad capabilities of larger corporate groups.

Economic Significance

An investment of approximately 22.2 million euros represents a substantial injection of capital into the regional healthcare supply chain. This spending supports local distribution networks, logistics operations, and clinical training programs, ensuring that advanced medical technologies remain accessible to public health facilities.

By securing these supplies through a competitive framework, the public sector protects its clinical operations from short term market volatility while fostering a sustainable ecosystem for medical device innovation.

Future Procurement Opportunities

Suppliers who were not successful should monitor the official Tenders Portal for upcoming medical device renewals in other Spanish regions. As clinical guidelines evolve, public institutions will continuously generate new tenders opportunities for advanced surgical supplies and implants.

Stakeholders should also track the Latest Active Tenders Procurement notices to anticipate upcoming infrastructure projects in the broader European healthcare sector. The dynamic nature of public procurement means that new Live Notices for Tenders will emerge as regional authorities update their clinical requirements.

Opportunities for Suppliers

While the primary framework positions have been awarded, specialized logistics providers and medical device distributors can find valuable subcontracting opportunities. Companies offering advanced inventory management software or specialized clinical training for hospital staff may also position themselves to support the supply chain operations of the awarded firms.

Additionally, manufacturers of niche surgical instruments or robotic surgery integration tools should monitor the reopening of competition phases to introduce next generation technologies to the Basque Health Service.

What Businesses Should Watch

Industry observers should monitor the activation rates for each lot to gauge the actual clinical demand for specialized knee prostheses in the Basque Country. The enforcement of strict technical evaluation criteria will be a key metric for future live tender evaluations in this sector.

Stakeholders should also review Live Notices for Tenders to anticipate upcoming medical modernization projects funded by regional health programs. The integration of robotic surgery compatibility and antiallergic materials will likely become standard requirements in future RFPs and RFQs.

SpainTenders.com Procurement Intelligence

This contract represents a clear trend in European public procurement toward the use of multi lot framework agreements with reopening of competition for highly specialized medical devices. By appointing numerous suppliers across 13 distinct lots, the contracting authority mitigates the risk of supply chain bottlenecks and ensures broad market access for critical surgical tools. This strategy prioritizes operational continuity and strict adherence to clinical mandates over the traditional model of awarding exclusive contracts to a single provider. Suppliers can learn that meeting fundamental technical requirements and providing verifiable clinical data is the primary gateway for winning public procurement contracts in the medical device sector.

Future contracts in this market are likely to evolve by incorporating even stricter material traceability and post market surveillance mandates. As public institutions face increasing pressure to ensure patient safety and optimize surgical outcomes, companies that proactively develop transparent supply chains and offer verifiable clinical data will hold a distinct advantage. Suppliers must prepare for increased scrutiny on their product certifications, making rigorous documentation and compliance tracking essential for future public procurement success. Monitoring Active Tenders and understanding the specific BOQs of regional health authorities will be critical for maintaining a competitive edge.

Supplier Takeaways

• Multi lot framework agreements with reopening of competition are increasingly used to guarantee supply chain resilience in public healthcare procurement.
• Meeting strict clinical and regulatory minimums is a primary gateway for winning government medical device contracts.
• Evaluation criteria heavily weighting technical quality and international registry data require suppliers to maintain high product certification levels.
• Specialized logistics and distribution providers can find valuable subcontracting opportunities with primary framework winners.

Key Takeaways

• Multiple specialized suppliers were awarded positions across 13 distinct knee prosthesis lots.
• The maximum awarded value of the framework agreements is 22,272,265.00 euros.
• The award criteria balanced technical quality and clinical evidence with a 50 percent weight to price.
• The procurement ensures a continuous supply of critical surgical implants for regional hospitals.
• All received bids originated from micro, small or medium enterprises.

Conclusion

This framework agreement secures a reliable and diversified supply of critical orthopedic devices for the Basque regional health system. The multi supplier award structure ensures competitive tension and operational resilience for the duration of the contract.

As the region continues to modernize its healthcare delivery, this procurement model will likely serve as a blueprint for future medical acquisitions across Spain.

Source: Tenders Electronic Daily (TED), Contract Award Notice 659844-2026, Official Journal of the European Union, published on 24/09/2026.